Order Article Reprints

Beldarrain G, Hilario E, Lara-Celador I, Chillida M, Catalan A, Álvarez-Diaz AÁ, Alonso-Alconada D. The Long-Term Neuroprotective Effect of the Endocannabinoid 2-AG and Modulation of the SGZ’s Neurogenic Response after Neonatal Hypoxia-Ischemia. Pharmaceutics. 2023; 15(6):1667. https://doi.org/10.3390/pharmaceutics15061667

Beldarrain, Gorane, Enrique Hilario, Idoia Lara-Celador, Marc Chillida, Ana Catalan, Antonia Ángeles Álvarez-Diaz, and Daniel Alonso-Alconada. 2023. "The Long-Term Neuroprotective Effect of the Endocannabinoid 2-AG and Modulation of the SGZ’s Neurogenic Response after Neonatal Hypoxia-Ischemia" Pharmaceutics 15, no. 6: 1667. https://doi.org/10.3390/pharmaceutics15061667

Beldarrain, G., Hilario, E., Lara-Celador, I., Chillida, M., Catalan, A., Álvarez-Diaz, A. Á., & Alonso-Alconada, D. (2023). The Long-Term Neuroprotective Effect of the Endocannabinoid 2-AG and Modulation of the SGZ’s Neurogenic Response after Neonatal Hypoxia-Ischemia. Pharmaceutics, 15(6), 1667. https://doi.org/10.3390/pharmaceutics15061667